Evidence for human transmission of amyloid-B pathology and cerebral amyloid
angiopathy, Singeltary Submission to Nature
2015-12-07 02:27 AM
From: Terry S. Singeltary Sr.
Sent: Friday, September 25, 2015 4:17 PM
Cc: h.pearson@nature.com ; a.abbott@nature.com ; q.schiermeier@nature.com ; c.stoddart@nature.com ; k.smith@nature.com
; j.collinge@ucl.ac.uk ; s.brandner@ucl.ac.uk
Subject: re-Evidence for human transmission of amyloid-β pathology
and cerebral amyloid angiopathy
Subject: re-Evidence for human transmission of amyloid-β pathology and
cerebral amyloid angiopathy
Greetings Nature et al,
WITH relations to the recent paper, and the Lancet paper and the media news
articles that followed ;
Evidence for human transmission of amyloid-β pathology and cerebral amyloid
angiopathy
Zane Jaunmuktane,1, Simon Mead,2, 3, 4, Matthew Ellis,3, Jonathan D. F.
Wadsworth,2, 3, Andrew J. Nicoll,2, 3, Joanna Kenny,2, 4, Francesca
Launchbury,3, Jacqueline Linehan,2, Angela Richard-Loendt,3, A. Sarah Walker,5,
Peter Rudge,2, 4, John Collinge2, 3, 4, & Sebastian Brandner1, 2, 3,
Affiliations Contributions Corresponding authors Journal name: Nature Volume:
525, Pages: 247–250 Date published: (10 September 2015) DOI:
doi:10.1038/nature15369 Received 26 April 2015 Accepted 14 August 2015 Published
online 09 September 2015 Updated online 11 September 2015 Erratum (September,
2015)
Alzheimergate? When miscommunication met sensationalism
www.thelancet.com Vol 386
September 19, 2015 1109
Wednesday, September 23, 2015
Science Government’s top doctor tried to discredit claims Alzheimer's might
be infectious Dame Sally Davies
Dailymail
Independent
I would kindly like to comment on the Nature Paper, the Lancet reply, and
the newspaper articles.
First, I applaud Nature, the Scientist and Authors of the Nature paper, for
bringing this important finding to the attention of the public domain, and the
media for printing said findings.
Secondly, it seems once again, politics is getting in the way possibly of
more important Transmissible Spongiform Encephalopathy TSE Prion scientific
findings. findings that could have great implications for human health, and
great implications for the medical surgical arena. but apparently, the
government peer review process, of the peer review science, tries to intervene
again to water down said disturbing findings.
where have we all heard this before? it’s been well documented via the BSE
Inquiry. have they not learned a lesson from the last time?
we have seen this time and time again in England (and other Country’s) with
the BSE mad cow TSE Prion debacle.
That ‘anonymous' Lancet editorial was disgraceful. The editor, Dick Horton
is not a scientist.
The pituitary cadavers were very likely elderly and among them some were on
their way to CJD or Alzheimer's. Not a bit unusual. Then the recipients — who
got pooled extracts injected from thousands of cadavers — were 100% certain to
have been injected with both seeds. No surprise that they got both diseases
going after thirty year incubations.
That the UK has a "system in place to assist science journalists" to squash
embargoed science reports they find ‘alarming’ is pathetic.
Sounds like the journalists had it right in the first place: “Alzheimer’s
may be a transmissible infection” in The Independent to “You can catch
Alzheimer’s” in The Daily Mirror or “Alzheimer’s bombshell" in The Daily
Express
if not for the journalist, the layperson would not know about these
important findings.
where would we be today with sound science, from where we were 30 years
ago, if not for the cloak of secrecy and save the industry at all cost
mentality?
when you have a peer review system for science, from which a government
constantly circumvents, then you have a problem with science, and humans die.
to date, as far as _documented_ body bag count, with all TSE prion _named_
to date, that count is still relatively low (one was too many in my case, Mom
hvCJD), however that changes drastically once the TSE Prion link is made with
Alzheimer’s, the price of poker goes up drastically.
so, who makes that final decision, and how many more decades do we have to
wait?
the iatrogenic mode of transmission of TSE prion, the many routes there
from, load factor, threshold from said load factor to sub-clinical disease, to
clinical disease, to death, much time is there to spread a TSE Prion to
anywhere, but whom, by whom, and when, do we make that final decision to do
something about it globally? how many _documented_ body bags does it take? how
many more decades do we wait? how many names can we make up for one disease, TSE
prion?
Professor Collinge et al, and others, have had troubles in the past with
the Government meddling in scientific findings, that might in some way involve
industry, never mind human and or animal health.
FOR any government to continue to circumvent science for monetary gain,
fear factor, or any reason, shame, shame on you.
in my opinion, it’s one of the reasons we are at where we are at to date,
with regards to the TSE Prion disease science i.e. money, industry, politics,
then comes science, in that order.
greed, corporate, lobbyist there from, and government, must be removed from
the peer review process of sound science, it’s bad enough having them in the
pharmaceutical aspect of healthcare policy making, in my opinion.
my mother died from confirmed hvCJD, and her brother (my uncle) Alzheimer’s
of some type (no autopsy?). just made a promise, never forget, and never let
them forget, before I do.
I kindly wish to remind the public of the past, and a possible future we
all hopes never happens again. ...
[9. Whilst this matter is not at the moment directly concerned with the
iatrogenic CJD cases from hgH, there remains a possibility of litigation here,
and this presents an added complication. There are also results to be made
available shortly (1) concerning a farmer with CJD who had BSE animals, (2) on
the possible transmissibility of Alzheimer’s and (3) a CMO letter on prevention
of iatrogenic CJD transmission in neurosurgery, all of which will serve to
increase media interest.]
2. The Collinge/Will dispute appears to rumble on. Dr. Collinge had told
Dr. Tyrrell that Dr. Will's response to his criticism about sharing material had
been ''quite unacceptable'' (in spite of it's apparently conciliatory tone).
Apparently Professor Allen was now going to try and arrange a meeting to resolve
the dispute. No action here for MAFF, although Mr. Murray may be interested.
3. Dr. Tyrrell regretted that the Committee had not seen the article on
BBD. However he felt that for the time being NO specific action was called for.
The most important need was to consider the possibility that the condition might
be transmissible. As we have discussed, I suggested that we might circulate a
paper to the members of the committee giving our appreciation of this condition
(and perhaps of other non-BSE neurological conditions that had been identified
in negative cases) and of any necessary follow up action. IF any Committee
member felt strongly about this, or if the issue CAME TO A HEAD, we would call
an interim meeting. He was happy with this approach. I would be grateful if Mr.
Maslin could, in discussion with CVL and veterinary colleagues draft such a
note, which will presumably very largely follow what Mr. Bradley's briefing
paper has already said, taking account of DOH comments, We can then clear a
final version with DOH before circulating it to Committee members.
http://web.archive.org/web/20050527055428/http://www.bseinquiry.gov.uk/files/yb/1992/10/29005001.pdf
IN CONFIDENCE This is a highly competitive field and it really will be a
pity if we allow many of the key findings to be published by overseas groups
while we are unable to pursue our research findings because of this
disagreement, which I hope we can make every effort to solve.
http://web.archive.org/web/20040315054541/http://www.bseinquiry.gov.uk/files/yb/1992/10/26002001.pdf
Self-Propagative Replication of Ab Oligomers Suggests Potential
Transmissibility in Alzheimer Disease
Received July 24, 2014; Accepted September 16, 2014; Published November 3,
2014
Singeltary comment Alzheimer’s, transmission, what if ???
Received July 24, 2014; Accepted September 16, 2014; Published November 3,
2014
*** IN STRICT CONFIDENCE ***
Singeltary comment ;
it was said long ago ;
Ann N Y Acad Sci. 1982;396:131-43.
Alzheimer's disease and transmissible virus dementia (Creutzfeldt-Jakob
disease).
Brown P, Salazar AM, Gibbs CJ Jr, Gajdusek DC.
Abstract
Ample justification exists on clinical, pathologic, and biologic grounds
for considering a similar pathogenesis for AD and the spongiform virus
encephalopathies. However, the crux of the comparison rests squarely on results
of attempts to transmit AD to experimental animals, and these results have not
as yet validated a common etiology. Investigations of the biologic similarities
between AD and the spongiform virus encephalopathies proceed in several
laboratories, and our own observation of inoculated animals will be continued in
the hope that incubation periods for AD may be even longer than those of CJD.
BSE101/1 0136
IN CONFIDENCE
5 NOV 1992 CMO From: Dr J S Metters DCMO 4 November 1992
TRANSMISSION OF ALZHEIMER TYPE PLAQUES TO PRIMATES
see full text and more IN CONFIDENCE ;
Self-Propagative Replication of Ab Oligomers Suggests Potential
Transmissibility in Alzheimer Disease
Received July 24, 2014; Accepted September 16, 2014; Published November 3,
2014
Singeltary comment Alzheimer’s, transmission, what if ???
RE: re-Human Prion Diseases in the United States
part 2 flounder replied to flounder on 02 Jan 2010 at 21:26 GMT
No competing interests declared.
see full text ;
(It was noted with concern that hormone extracts could be manufactured by a
veterinary surgeon for administration to animals under his care without any
Medicines Act Control.)
PITUITARY EXTRACT
This was used to help cows super ovulate.
*** This tissue was considered to be of greatest risk of containing BSE and
consequently transmitting the disease. ***
LMAO (it will load correctly, but nothing there)
COMMERCIAL IN CONFIDENCE NOT FOR PUBLICATION
http://web.archive.org/web/20030515185220/http://www.bseinquiry.gov.uk/files/yb/1989/01/30001001.pdf
http://web.archive.org/web/20041029112433/http://www.bseinquiry.gov.uk/files/yb/1989/09/06011001.pdf
2.1.2 Allergy Products
snip...
Comment
2.1.3 ________________________, England Ltd) ***contains bovine heart and
brain sourced from USA***. (It also uses UK derived equine blood.)
http://web.archive.org/web/20041029112433/http://www.bseinquiry.gov.uk/files/yb/1989/09/06011001.pdf
THE VETERINARY RECORD 516 No 47. Vol. 58 November 23rd, 1946
NATIONAL VETERINARY MEDICAL ASSOCIATION OF GREAT BRITAIN AND IRELAND ANNUAL
CONGRESS, 1946 Advances in Veterinary Research
Louping-ill, Tick-borne Fever and Scrapie W.S. GORDON, PH.D., M.R.C.V.S.,
F.R.S.E. Agriculteral Research Council, Field Station, Compton, Berks.
"Vaccine for issue had to be free from detectable, living virus and capable
of protecting sheep against a test dose of virus applied subcutaneously. The
1935 vaccine conformed to these standards and was issued for inoculation in
March as three separate batches labelled 1, 2, and 3. The tissues of 140 sheep
were employed to make batch 1 of which 22,270 doses were used; 114 to make batch
2 of which 18,000 doses were used and 44 to make batch 3 of which 4,360 doses
were used. All the sheep tissues incorporated in the vaccine were obtained from
yearling sheep. During 1935 and 1936 the vaccine proved highly efficient in the
prevention of loup-ill and no user observed an ill-effect in the inoculated
animals.
In September, 1937, two and a half years after vaccinating the sheep, two
owners complained that scrapie, a disease which had not before been observed in
the Blackface breed, was appearing in their stock of Blackface sheep and further
that it was confined to animals vaccinated with louping-ill vaccine in 1935.
At that stage it was difficult to conceive that the occurrence could be
associated with the injection of the vaccine but in view of the implications, I
visited most of the farms on which sheep had been vaccinated in 1935. It was at
this point that the investigation reached its dramatic phase; I shall not forget
the profound effect on my emotions when I visited these farms and was warmly
welcomed because of the great benefits resulting from the application of
louping-ill vaccine, wheras the chief purpose of my visit was to determine if
scrapie was appearing in the inoculated sheep.
The enquiry made the position clear. Scrapie was developing in the sheep
vaccinated in 1935 and it was only in a few instances that the owner was
associating the occurrence with louping-ill vaccination. The disease was
affecting all breeds and it was confined to the animals vaccinated with batch 2.
This was clearly demonstrated on a number of farms on which batch 1 had been
used to inoculate the hoggs in 1935 and batch 2 to inoculate the ewes. None of
the hoggs, which at this time were three- year-old ewes.
At this time it was difficult to forecast whether all of the 18,000 sheep
which had received batch 2 vaccine would develop scrapie. It was fortunate,
however, that the majority of the sheep vaccinated with batch 2 were ewes and
therfore all that were four years old and upwards at the time of vaccination had
already been disposed of [[eaten for human food]] and there only remained the
ewes which had been two to three years old at the time of vaccination,
consequently no accurate assessment of the incidence of scrapie could be made.
On a few farms, however, where vaccination was confined to hoggs, the incidence
ranged from 1 percent, to 35 percent, with an average of about 5 percent.
Since batch 2 vaccine had been incriminated as a probable source of scrapie
infection, an attempt was made to trace the origin of the 112 sheep whose
tissues had been included in the vaccine. It was found that they had been
supplied by three owners and that all were of the Blackface or Greyface breed
with the exception of eight which were Cheviot lambs born in 1935 from ewes
which had been in contact with scrapie infection. Some of these contact ewes
developed scrapie in 1936-37 and three surviving fellow lambs to the eight
included in the batch 2 vaccine of 1935 developed scrapie, one in September,
1936, one in February, 1937, and one in November, 1937.
There was, therefore, strong presumptive evidence that the eight Cheviot
lambs included in the vaccine althought apparently healthy were, in fact, in the
incubative stage of a scrapie infection and that in their tissues there was an
infective agent which had contaminated the batch 2 vaccine, rendering it liable
to set up scrapie.
If that assumption was correct then the evidence indicated that: (1) the
infective agent of scrapie was present in the brain, spinal cord and or spleen
of infected sheep: (2) it could withstand a concentration of formalin of 0-35
percent, which inactivated the virus of louping-ill: (3) it could be transmitted
by subcutaneous inoculation; (4) it had an incubative period of two years and
longer."
see part of old report I received;
*** An interview with Professor John Collinge: Director of the MRC Prion
Unit. Part of the Hayward Gallery's History Is Now.
culture of denial...SEE VIDEO ;
*** see vaccines (I don’t advertise or make money from these blogs, they
are for educational use for the TSE Prion disease and to document history) ;
*** U.S.A. 50 STATE EMERGENCY BSE MAD COW CONFERENCE CALL Jan. 9, 2001
IBNC Tauopathy or TSE Prion disease, it appears, no one is sure
Singeltary et al
Posted by flounder on 03 Jul 2015 at 16:53 GMT
31 Jan 2015 at 20:14 GMT
*** Ruminant feed ban for cervids in the United States? ***
31 Jan 2015 at 20:14 GMT
*** Singeltary reply ; Molecular, Biochemical and Genetic Characteristics
of BSE in Canada Singeltary reply ;
Diagnosis and Reporting of Creutzfeldt-Jakob Disease Singeltary, Sr et al.
JAMA.2001; 285: 733-734. Vol. 285 No. 6, February 14, 2001 JAMA
Diagnosis and Reporting of Creutzfeldt-Jakob Disease
To the Editor: In their Research Letter, Dr Gibbons and colleagues1
reported that the annual US death rate due to Creutzfeldt-Jakob disease (CJD)
has been stable since 1985. These estimates, however, are based only on reported
cases, and do not include misdiagnosed or preclinical cases. It seems to me that
misdiagnosis alone would drastically change these figures. An unknown number of
persons with a diagnosis of Alzheimer disease in fact may have CJD, although
only a small number of these patients receive the postmortem examination
necessary to make this diagnosis. Furthermore, only a few states have made CJD
reportable. Human and animal transmissible spongiform encephalopathies should be
reportable nationwide and internationally.
Terry S. Singeltary, Sr Bacliff, Tex
1. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob
disease in the United States: 1979-1998. JAMA. 2000;284:2322-2323. FREE FULL
TEXT
Views & Reviews
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in
the United States
Ermias D. Belay, MD, Ryan A. Maddox, MPH, Pierluigi Gambetti, MD and
Lawrence B. Schonberger, MD
+ Author Affiliations
From the Division of Viral and Rickettsial Diseases (Drs. Belay and
Schonberger and R.A. Maddox), National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, GA; and National Prion Disease
Pathology Surveillance Center (Dr. Gambetti), Division of Neuropathology,
Institute of Pathology, Case Western Reserve University, Cleveland, OH.
Address correspondence and reprint requests to Dr. Ermias D. Belay, 1600
Clifton Road, Mailstop A-39, Atlanta, GA 30333.
26 March 2003
Terry S. Singeltary, retired (medically) CJD WATCH
I lost my mother to hvCJD (Heidenhain Variant CJD). I would like to comment
on the CDC's attempts to monitor the occurrence of emerging forms of CJD.
Asante, Collinge et al [1] have reported that BSE transmission to the
129-methionine genotype can lead to an alternate phenotype that is
indistinguishable from type 2 PrPSc, the commonest sporadic CJD. However, CJD
and all human TSEs are not reportable nationally. CJD and all human TSEs must be
made reportable in every state and internationally. I hope that the CDC does not
continue to expect us to still believe that the 85%+ of all CJD cases which are
sporadic are all spontaneous, without route/source. We have many TSEs in the USA
in both animal and man. CWD in deer/elk is spreading rapidly and CWD does
transmit to mink, ferret, cattle, and squirrel monkey by intracerebral
inoculation. With the known incubation periods in other TSEs, oral transmission
studies of CWD may take much longer. Every victim/family of CJD/TSEs should be
asked about route and source of this agent. To prolong this will only spread the
agent and needlessly expose others. In light of the findings of Asante and
Collinge et al, there should be drastic measures to safeguard the medical and
surgical arena from sporadic CJDs and all human TSEs. I only ponder how many
sporadic CJDs in the USA are type 2 PrPSc?
The Lancet Infectious Diseases, Volume 3, Issue 8, Page 463, August 2003
doi:10.1016/S1473-3099(03)00715-1Cite or Link Using DOI
Tracking spongiform encephalopathies in North America
Original
Xavier Bosch
“My name is Terry S Singeltary Sr, and I live in Bacliff, Texas. I lost my
mom to hvCJD (Heidenhain variant CJD) and have been searching for answers ever
since. What I have found is that we have not been told the truth. CWD in deer
and elk is a small portion of a much bigger problem.” 49-year—old Singeltary is
one of a number of people who have remained largely unsatisfied after being told
that a close relative died from a rapidly progressive dementia compatible with
spontaneous Creutzfeldt—Jakob ...
2 January 2000
British Medical Journal
U.S. Scientist should be concerned with a CJD epidemic in the U.S., as well
15 November 1999
British Medical Journal
vCJD in the USA * BSE in U.S.
2012 Singeltary
Alzheimer’s disease and Transmissible Spongiform Encephalopathy prion
disease, Iatrogenic, what if ?
Background
Alzheimer’s disease and Transmissible Spongiform Encephalopathy disease
have both been around a long time, and was discovered in or around the same time
frame, early 1900’s. Both diseases are incurable and debilitating brain disease,
that are in the end, 100% fatal, with the incubation/clinical period of the
Alzheimer’s disease being longer (most of the time) than the TSE prion disease.
Symptoms are very similar, and pathology is very similar.
Methods
Through years of research, as a layperson, of peer review journals,
transmission studies, and observations of loved ones and friends that have died
from both Alzheimer’s and the TSE prion disease i.e. Heidenhain Variant
Creutzfelt Jakob Disease CJD.
Results
I propose that Alzheimer’s is a TSE disease of low dose, slow, and long
incubation disease, and that Alzheimer’s is Transmissible, and is a threat to
the public via the many Iatrogenic routes and sources. It was said long ago that
the only thing that disputes this, is Alzheimer’s disease transmissibility, or
the lack of. The likelihood of many victims of Alzheimer’s disease from the many
different Iatrogenic routes and modes of transmission as with the TSE prion
disease.
Conclusions
There should be a Global Congressional Science round table event set up
immediately to address these concerns from the many potential routes and sources
of the TSE prion disease, including Alzheimer’s disease, and a emergency global
doctrine put into effect to help combat the spread of Alzheimer’s disease via
the medical, surgical, dental, tissue, and blood arena’s. All human and animal
TSE prion disease, including Alzheimer’s should be made reportable in every
state, and Internationally, WITH NO age restrictions. Until a proven method of
decontamination and autoclaving is proven, and put forth in use universally, in
all hospitals and medical, surgical arena’s, or the TSE prion agent will
continue to spread. IF we wait until science and corporate politicians wait
until politics lets science _prove_ this once and for all, and set forth
regulations there from, we will all be exposed to the TSE Prion agents, if that
has not happened already.
end...tss
SEE FULL TEXT AND SOURCE REFERENCES ;
Wednesday, May 16, 2012
Alzheimer’s disease and Transmissible Spongiform Encephalopathy prion
disease, Iatrogenic, what if ?
Proposal ID: 29403
From:
Sent: Saturday, April 07, 2012 8:20 PM
To: Terry S. Singeltary Sr.
Subject: RE: re-submission
Dear Terry,
Yes, your proposal was accepted as a poster presentation. Please decline
the invitation if appropriate.
Best Regards,
______________________________________
Alzheimer’s Association – National Office
225 North Michigan Avenue – Floor 17
Chicago, Illinois 60601
=============snip...end...source reference...# 29403==========
Wednesday, September 2, 2015
Clinically Unsuspected Prion Disease Among Patients With Dementia Diagnoses
in an Alzheimer’s Disease Database
Thursday, July 30, 2015
Professor Lacey believes sporadic CJD itself originates from a cattle
infection number of cattle farmers falling victim to Creutzfeld-Jakob Disease is
much too high to be mere chance
Wednesday, September 23, 2015
*** NIH Availability for Licensing AGENCY: [FR Doc. 2015–24117 Filed
9–22–15; 8:45 am] Detection and Discrimination of Classical and Atypical L-Type
BSE Strains by RT-QuIC
Thursday, September 10, 2015
TSEAC FDA TSE PRION MAD COW CIRCUS AND TRAVELING ROAD SHOW (their
words)
25th Meeting of the Transmissible Spongiform Encephalopathies Advisory
Committee Food and Drug Administration Silver Spring, Maryland June 1, 2015
Thursday, August 13, 2015
Iatrogenic CJD due to pituitary-derived growth hormone with genetically
determined incubation times of up to 40 years
Monday, August 17, 2015
FDA Says Endoscope Makers Failed to Report Superbug Problems OLYMPUS
I told Olympus 15 years ago about these risk factors from endoscopy
equipment, disinfection, even spoke with the Doctor at Olympus, this was back in
1999. I tried to tell them that they were exposing patients to dangerous
pathogens such as the CJD TSE prion, because they could not properly clean them.
even presented my concern to a peer review journal GUT, that was going to
publish, but then it was pulled by Professor Michael Farthing et al... see ;
Friday, January 10, 2014
vpspr, sgss, sffi, TSE, an iatrogenic by-product of gss, ffi, familial type
prion disease, what it ???
Thursday, September 24, 2015
TEXAS Hunters Asked to Submit Samples for Chronic Wasting Disease CWD TSE
Prion Testing
*** I cannot stress enough to all of you, for the sake of your family and
mine, before putting anything in the freezer, have those deer tested for CWD.
...terry
cwd to humans, iatrogenic, what if ?
Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes
contaminated during neurosurgery.
Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC.
Laboratory of Central Nervous System Studies, National Institute of Neurological
Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Stereotactic multicontact electrodes used to probe the cerebral cortex of a
middle aged woman with progressive dementia were previously implicated in the
accidental transmission of Creutzfeldt-Jakob disease (CJD) to two younger
patients. The diagnoses of CJD have been confirmed for all three cases. More
than two years after their last use in humans, after three cleanings and
repeated sterilisation in ethanol and formaldehyde vapour, the electrodes were
implanted in the cortex of a chimpanzee. Eighteen months later the animal became
ill with CJD. This finding serves to re-emphasise the potential danger posed by
reuse of instruments contaminated with the agents of spongiform
encephalopathies, even after scrupulous attempts to clean them.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8006664&dopt=Abstract
Tuesday, May 26, 2015
*** Minimise transmission risk of CJD and vCJD in healthcare settings
***
Last updated 15 May 2015
Wednesday, September 23, 2015
Alzheimergate? When miscommunication met
sensationalism, or just another cover up ?
Terry S. Singeltary Sr., Bacliff, Texas USA 77518 flounder9@verizon.net
No comments:
Post a Comment